Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BenQ Medical TechnologyROCO:4116 -0.75%86 EV-to-EBITDA is 5.38 as of Sep. 13, 2026, which is 32% below its 10-year median of 7.92. GuruFocus rates ROCO:4116 with a GF Score™ of 86/100 and a GF Value™ of NT$55.26 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 515 Medical Devices & Instruments companies, BenQ Medical Technology ranks better than 86.02% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BenQ Medical Technology's enterprise value is NT$3,904 Mil.
BenQ Medical Technology's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$726 Mil. Therefore, BenQ Medical Technology's EV-to-EBITDA for today is 5.38.
The historical rank and industry rank for BenQ Medical Technology's EV-to-EBITDA or its related term are showing as below:
ROCO:4116'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.94 Med: 7.92 Max: 27.39
Current: 5.38
During the past 13 years, the highest EV-to-EBITDA of BenQ Medical Technology was 27.39. The lowest was 4.94. And the median was 7.92.
ROCO:4116's EV-to-EBITDA is ranked better than 86.02% of 515
companies
in the Medical Devices & Instruments industry
Industry Median: 13.63
vs ROCO:4116: 5.38
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
BenQ Medical Technology (ROCO:4116) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BenQ Medical Technology's PE Ratio (TTM) for today is calculated as:
BenQ Medical Technology's share price for today is NT$39.60.
BenQ Medical Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2.622.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4116 vs ISRG, BDX, RMD: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, BenQ Medical Technology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BenQ Medical Technology EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BenQ Medical Technology's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where BenQ Medical Technology's EV-to-EBITDA falls into.
BenQ Medical Technology's current Enterprise Value is NT$3,904 Mil.
BenQ Medical Technology's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$726 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BenQ Medical Technology (ROCO:4116) has a EV-to-EBITDA of 5.38 as of Sep. 13, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on BenQ Medical Technology. This is 32% below median its historical median of 7.92. Over the past decade, BenQ Medical Technology's EV-to-EBITDA has ranged from 4.94 to 27.39. According to the industry distribution chart, BenQ Medical Technology ranks #72 out of 515 companies in the Medical Devices & Instruments industry, placing it in the top 14%.
Is BenQ Medical Technology's EV-to-EBITDA too high?
BenQ Medical Technology's current EV-to-EBITDA of 5.38 is 32% below median its 10-year median of 7.92. Over the past 10 years, this metric has ranged from a low of 4.94 to a high of 27.39. The Medical Devices & Instruments industry median EV-to-EBITDA is 13.63. BenQ Medical Technology's value of 5.38 is 60.5% below this industry median. Based on the distribution chart, BenQ Medical Technology ranks #72 out of 515 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, BenQ Medical Technology has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BenQ Medical Technology's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BenQ Medical Technology ranks #72 out of 515 companies for EV-to-EBITDA. This places BenQ Medical Technology in the top 14% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 13.63. BenQ Medical Technology's value of 5.38 is 60.5% below this benchmark. Historically, BenQ Medical Technology's own EV-to-EBITDA has ranged from 4.94 to 27.39 over the past decade. While the company's 10-year median is 7.92 vs. the industry median of 13.63, BenQ Medical Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 13.63, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BenQ Medical Technology's current EV-to-EBITDA of 5.38 is 60.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on BenQ Medical Technology. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 13.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BenQ Medical Technology's current EV-to-EBITDA is 5.38, which is 32% below median its own 10-year median of 7.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, BenQ Medical Technology (ROCO:4116) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$55.26, compared to a current price of NT$39.60 — trading 28.3% below its estimated fair value. The current EV-to-EBITDA is 5.38, which is 32% below median its 10-year median of 7.92 and 60.5% below the Medical Devices & Instruments industry median of 13.63. BenQ Medical Technology's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For BenQ Medical Technology (ROCO:4116), the current EV-to-EBITDA is 5.38 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?
Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued.
The current stock price of NT$39.60 is trading 28.3% below its estimated GF Value™ of NT$55.26.
GuruFocus considers BenQ Medical Technology to be Modestly Undervalued.
Key valuation signals for ROCO:4116:
EV-to-EBITDA: 5.38 (32% below median its 10-year median of 7.92)
GF Value™: NT$55.26 vs. price of NT$39.60 (28.3% below fair value)
Industry Position: 60.5% below the Medical Devices & Instruments median (#72 of 515)
No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
86GF Score
Get the complete analysis for ROCO:4116
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4116 has been successfully added to your 
